NDUFS2

NDUFS2 is a core catalytic subunit of mitochondrial respiratory chain complex I (NADH:ubiquinone oxidoreductase) that resides at the interface of the peripheral and membrane arms near the ubiquinone-binding pocket and is essential for electron transfer, proton pumping, and cellular ATP production (PMID:22036843, PMID:33744462). Arginine-85 of NDUFS2 undergoes symmetric dimethylation by the assembly factor NDUFAF7 early during peripheral arm biogenesis, stabilizing a ~400-kDa assembly intermediate (PMID:24089531), while OTUB1-mediated removal of K48-linked polyubiquitin chains controls NDUFS2 protein stability (PMID:38653740). Beyond its bioenergetic role, NDUFS2 cysteine residues function as redox-sensitive oxygen sensors in pulmonary artery and ductus arteriosus smooth muscle cells, coupling changes in mitochondrial H₂O₂ to intracellular Ca²⁺ signaling and vascular tone (PMID:30922174). Biallelic loss-of-function mutations in NDUFS2 cause mitochondrial complex I deficiency presenting as Leigh-like encephalopathy or isolated optic neuropathy (PMID:11220739, PMID:28031252).

1. 2001 High

   Identification of patient missense mutations established NDUFS2 as a nuclear-encoded structural/functional subunit whose integrity is required for complex I enzymatic activity.

   Evidence RT-PCR, DNA sequencing, and biochemical complex I assay in patient fibroblasts from multiple families

   PMID:11220739

   Open questions at the time

   • Precise catalytic role of NDUFS2 within complex I was not defined
   • No structural localization of the mutated residues within the complex
2. 2011 High

   Demonstration that the Asp446Asn mutation impairs catalysis without reducing complex I abundance, combined with structural modeling placing Asp446 near the ubiquinone-binding pocket, positioned NDUFS2 as a catalytic subunit at the electron-transfer/proton-pumping interface.

   Evidence Complex I activity and CoQ-analog KM measurements in patient fibroblasts; 3D modeling; lentiviral wild-type NDUFS2 rescue

   PMID:22036843

   Open questions at the time

   • Direct structural evidence for the ubiquinone-binding pocket architecture was lacking in the mammalian complex
   • Mechanism by which Asp446 participates in catalysis not resolved at atomic level
3. 2013 High

   Discovery that NDUFAF7 symmetrically dimethylates Arg-85 of NDUFS2 during early assembly revealed a post-translational modification step that nucleates peripheral arm biogenesis.

   Evidence Mass spectrometry identification of dimethyl-Arg-85; in vitro methyltransferase assay; subcomplex isolation

   PMID:24089531

   Open questions at the time

   • Functional consequence of blocking Arg-85 methylation on assembled complex I activity was not determined
   • Whether other complex I subunits are co-dependently modified at this stage is unknown
4. 2016 Medium

   Functional analysis of compound heterozygous NDUFS2 mutations in a yeast ortholog system demonstrated allele-specific severity and established a genotype–phenotype correlation with non-syndromic optic neuropathy, expanding the clinical spectrum beyond encephalopathy.

   Evidence Whole-exome sequencing; patient fibroblast biochemistry; Yarrowia lipolytica NUCM mutagenesis with complex I activity assays

   PMID:28031252

   Open questions at the time

   • Yeast ortholog system may not fully recapitulate mammalian assembly or tissue-specific phenotypes
   • Why optic nerve is selectively vulnerable to these particular mutations remains unexplained
5. 2019 High

   NDUFS2 was identified as the molecular oxygen sensor in pulmonary artery smooth muscle cells, with its cysteine residues undergoing redox changes during hypoxia that decrease mitochondrial H₂O₂ and trigger Ca²⁺-dependent vasoconstriction — a function not shared by other ETC subunits tested.

   Evidence siRNA knockdown of NDUFS2 and control subunits in PASMCs; intracellular Ca²⁺ imaging; H₂O₂ and NADH/NAD⁺ measurements; cysteine redox profiling; isolated lung bioassay; in vivo siNdufs2 challenge

   PMID:30922174

   Open questions at the time

   • Identity of the specific cysteine residues responsible for oxygen sensing was not determined
   • Whether this oxygen-sensing mechanism operates in vascular beds beyond pulmonary vasculature was untested
6. 2021 High

   CRISPR knockout of NDUFS2 in human cells confirmed it is indispensable for complex I-linked respiration and cell viability, and showed that the CoQ analog idebenone can partially bypass the defect.

   Evidence CRISPR/Cas9 KO in HEK293; Seahorse respirometry; ROS, ATP, and viability assays; idebenone rescue

   PMID:33744462

   Open questions at the time

   • Idebenone rescue was partial — the electron entry point bypassing complex I was not resolved
   • No in vivo validation of idebenone benefit for NDUFS2 deficiency
7. 2022 Medium

   Modeling disease-causing NDUFS2 mutations in the bacterial ortholog nuoCD showed that mutations at subunit interfaces disrupt complex I assembly, providing a structural rationale for genotype–severity correlations.

   Evidence Site-directed mutagenesis of E. coli nuoCD; membrane vesicle NADH oxidase assays; co-IP assembly assays

   PMID:36462614

   Open questions at the time

   • Bacterial system lacks accessory subunits and assembly factors present in mammalian complex I
   • Assembly kinetics were inferred from endpoint assays, not real-time tracking
8. 2024 High

   The lncRNA DCRT was shown to prevent PTBP1-mediated exon 3 skipping of NDUFS2 in cardiomyocytes; loss of DCRT produces a truncated dominant-negative NDUFS2 isoform that inhibits complex I and sequesters PRDX5, causing dilated cardiomyopathy.

   Evidence CRISPR DCRT-KO mice; RNA immunoprecipitation; isoform sequencing; co-IP of truncated NDUFS2 with PRDX5; complex I assays; AAV rescue

   PMID:38841852

   Open questions at the time

   • Whether exon 3-skipped NDUFS2 isoform exists at physiologically relevant levels in human heart disease is unknown
   • Stoichiometry and structural basis of truncated NDUFS2–PRDX5 interaction not resolved
9. 2024 Medium

   OTUB1 was identified as a deubiquitinase that stabilizes NDUFS2 by removing K48-linked polyubiquitin chains, linking ubiquitin-dependent protein quality control to complex I abundance in cancer cells.

   Evidence Co-IP and mass spectrometry; OTUB1 overexpression/knockdown with NDUFS2 protein measurement; ubiquitination assay; xenograft models

   PMID:38653740

   Open questions at the time

   • The E3 ubiquitin ligase that ubiquitinates NDUFS2 is unknown
   • Whether OTUB1-NDUFS2 regulation occurs in non-cancer physiological contexts is untested
   • Deubiquitination site(s) on NDUFS2 were not mapped

• Key unresolved questions include: the identity of the specific NDUFS2 cysteine residues that mediate oxygen sensing, the structural basis by which the truncated exon 3-skipped isoform exerts dominant-negative effects, and whether NDUFS2 ubiquitin-dependent turnover is a regulated axis in mitochondrial quality control beyond cancer.
• No high-resolution structure of NDUFS2 in the context of mammalian complex I with defined oxygen-sensing cysteines
• No in vivo therapeutic validation of idebenone or folic acid for NDUFS2-deficient patients
• The E3 ligase targeting NDUFS2 for ubiquitin-proteasomal degradation has not been identified